Literature DB >> 25379977

Microvascular abnormalities in patients with early systemic sclerosis: less severe morphological changes than in patients with definite disease.

C Z Camargo1, J Y Sekiyama, M I Arismendi, C Kayser.   

Abstract

OBJECTIVES: To evaluate the morphological and functional abnormalities of the microcirculation associated with markers of vascular injury in patients with early systemic sclerosis (SSc).
METHOD: Forty-six patients with early SSc were compared with 80 patients with definite SSc, 40 patients with primary Raynaud's phenomenon (PRP), and 45 healthy subjects. Widefield nailfold capillaroscopy (NFC) (10-25 × magnification), videocapillaroscopy (200 × magnification), and laser Doppler imaging (LDI) assessment were performed in all participants. The number of capillaries/mm, enlarged, giant and ramified capillaries, microhaemorrhages, and the avascular score were determined by widefield NFC and videocapillaroscopy. Fingertip blood flow (FBF) was measured using LDI before and after cold stimulus (CS). Serum endothelin-1 (ET-1), von Willebrand factor (vWF), and transforming growth factor beta-1 (TGF-β1) were measured by enzyme-linked immunosorbent assay (ELISA).
RESULTS: Upon both widefield NFC and videocapillaroscopy, patients with early SSc showed significantly higher numbers of capillaries/mm, lower enlarged and giant capillaries, and a lower avascular score than definite SSc patients (p < 0.001). They also had more enlarged capillaries, microhaemorrhages and a higher avascular score compared to PRP and controls (p < 0.001). FBF before and after CS were significantly higher in controls than in PRP, early SSc, and definite SSc patients (p < 0.001), with no difference between early and definite SSc. Serum levels of ET-1, vWF, and TGF-β1 were similar between early and definite SSc patients.
CONCLUSIONS: Early SSc patients showed functional changes and vascular injury marker levels similar to patients with established disease. Nonetheless, the morphological changes were less severe in early SSc, thus providing an opportunity for further prevention of vasculopathy progression.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25379977     DOI: 10.3109/03009742.2014.926566

Source DB:  PubMed          Journal:  Scand J Rheumatol        ISSN: 0300-9742            Impact factor:   3.641


  2 in total

1.  CXCL4 in undifferentiated connective tissue disease at risk for systemic sclerosis (SSc) (previously referred to as very early SSc).

Authors:  Gabriele Valentini; Antonella Riccardi; Serena Vettori; Rosaria Irace; Michele Iudici; Salvatore Tolone; Ludovico Docimo; Marialuisa Bocchino; Alessandro Sanduzzi; Domenico Cozzolino
Journal:  Clin Exp Med       Date:  2016-09-20       Impact factor: 3.984

2.  State-of-the-art technologies provide new insights linking skin and blood vessel abnormalities in SSc-related disorders.

Authors:  Graham Dinsdale; Sarah Wilkinson; Jack Wilkinson; Tonia L Moore; Joanne B Manning; Michael Berks; Elizabeth Marjanovic; Mark Dickinson; Ariane L Herrick; Andrea K Murray
Journal:  Microvasc Res       Date:  2020-04-19       Impact factor: 3.514

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.